Cagrilintide + Semaglutide

What is Cagrilintide + Semaglutide?

This prefilled pen combines Cagrilintide, an amylin analogue, with Semaglutide, a GLP-1 receptor agonist — two peptides acting on complementary appetite pathways.

Produced in a GMP-certified facility, filled to a consistent concentration and batch-tested for purity. Supplied for research use only.

What is this combination researched for?

In research settings, the pairing is studied for its role in:

• Dual pathway signalling: combined amylin and GLP-1 receptor activity.
• Appetite regulation: satiety and food-intake endpoints in models.
• Glucose handling: glycemic markers in study designs.
• Body-weight endpoints: adiposity markers in preclinical research.

Information on this page is provided for research and educational context only and does not constitute medical advice or a therapeutic claim.